Related Experiment Videos
Docetaxel neuropathy: a distal axonopathy
R Fazio1, A Quattrini, A Bolognesi
1Department of Neurology, San Raffaele Scientific Institute, Via Olgettina 60, I-20132 Milan, Italy.
Acta Neuropathologica
|December 22, 1999
Summary
Docetaxel can cause peripheral neuropathy, a nerve damage condition. Pathological nerve changes and recovery after stopping docetaxel treatment were observed in a patient with sensorimotor polyneuropathy.
Area of Science:
- Neurology
- Oncology
- Pathology
Background:
- Docetaxel is a chemotherapy agent known to potentially cause peripheral neuropathy.
- Pathological evidence describing nerve changes associated with docetaxel-induced neuropathy is limited.
Observation:
- A 54-year-old male patient developed sensorimotor polyneuropathy during docetaxel treatment (540 mg/m²).
- Neurophysiological tests indicated a sensorimotor axonal neuropathy.
- Sural nerve biopsy revealed axonal damage with a predominant loss of large myelinated fibers and signs of regeneration.
Findings:
- The patient's condition presented as an axonal neuropathy.
- Histopathological examination confirmed significant loss of large myelinated nerve fibers.
- Evidence of nerve fiber regeneration was noted during the biopsy.
Implications:
- This case provides pathological description of docetaxel-induced peripheral neuropathy.
- The findings highlight the potential for nerve regeneration and symptom improvement upon docetaxel cessation.
- Understanding these pathological changes can aid in managing chemotherapy-related nerve damage.